ArticleOxidative medicine and cellular longevity2022

KIF11 As a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses.

Xiuhong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.